Diaceutics PLC (AIM: DXRX)

Diaceutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	106	73	64	86	112	71
Market Cap Growth	50.88%	15.14%	-25.74%	-23.60%	58.13%	-
Enterprise Value	90	57	45	62	83	57
Last Close Price	1.25	0.87	0.76	1.02	1.33	1.02
PE Ratio	-	-	87.95	152.85	426.74	178.33
Forward PE	-	-	30.32	40.80	109.73	86.44
PS Ratio	4.06	3.09	3.26	6.15	8.84	5.28
PB Ratio	2.74	1.80	1.50	2.11	2.79	3.53
P/TBV Ratio	4.46	2.87	2.32	3.06	3.59	3.78
P/FCF Ratio	64.64	61.82	12.97	17150.06	967.52	-
P/OCF Ratio	61.23	55.93	12.50	150.44	443.60	-
EV/Sales Ratio	3.46	2.39	2.29	4.46	6.50	4.25
EV/EBITDA Ratio	-	555.87	21.53	40.96	194.30	24.93
EV/EBIT Ratio	-	-	77.74	112.96	-	27.35
EV/FCF Ratio	55.12	47.81	9.10	12425.86	711.89	-
Debt / Equity Ratio	0.03	0.03	0.03	0.04	0.00	0.01
Debt / EBITDA Ratio	-	4.73	0.60	1.00	0.28	0.05
Debt / FCF Ratio	0.69	1.02	0.27	312.20	1.02	-
Asset Turnover	0.57	0.50	0.42	0.31	0.39	0.89
Quick Ratio	4.71	6.11	8.07	11.24	11.33	8.08
Current Ratio	4.85	6.40	8.23	11.41	11.53	8.23
Return on Equity (ROE)	-7.13%	-4.19%	1.74%	1.39%	0.87%	3.50%
Return on Assets (ROA)	-6.06%	-3.99%	0.77%	0.78%	-0.51%	8.65%
Return on Capital (ROIC)	-6.75%	-4.40%	0.84%	0.83%	-0.56%	9.81%
Earnings Yield	-2.63%	-2.38%	1.14%	0.65%	0.23%	0.56%
FCF Yield	1.52%	1.62%	7.71%	0.01%	0.10%	-1.03%
Buyback Yield / Dilution	2.10%	2.16%	-1.35%	-9.14%	-21.29%	-42.92%
Total Shareholder Return	2.10%	2.16%	-1.35%	-9.14%	-21.29%	-42.92%

Source: S&P Capital IQ. Standard template. Financial Sources.